Publication | Closed Access

Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation

Hematological MalignancyTransplantationPharmacogenomic AssociationsKidney TransplantMedicineImmunologyHematologyPharmacologyPharmacogenomicsAcute Kidney InjuryChronic Kidney DiseaseMyeloid Neoplasia